A STAT6 gene polymorphism is associated with high infection levels in urinary schistosomiasis

Genes and Immunity

Volumn 9, Issue 3, 2008, Pages 195-206

  He, H ^a,b   Isnard, A ^a,b   Kouriba, B ^c   Cabantous, S ^a,b   Dessein, A ^a,b   Doumbo, O ^c   Chevillard, C ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY OF BAMAKO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; FEMALE; FRANCE; GEL MOBILITY SHIFT ASSAY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RATE; INFECTION SENSITIVITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL;

ELECTROPHORETIC MOBILITY SHIFT ASSAY; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALI; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SCHISTOSOMIASIS HAEMATOBIA; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS;

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM;

EID: 42949133369     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.2     Document Type: Article

References (81)

1. Smith JH, Christie JD. The pathobiology, of Schistosoma haematobium infection in humans. Hum Pathol 1986; 17: 333-345.
2. Bogliolo L. Anatomical aspect of the liver in hepato-splenic form of Manson~s schistosomiasis. Hospital (Rio J) 1954; 45: 283-306.
3. Rey L. Parasitologia. Guanabara K (ed). 3rd edn. Sociedade brasileiro de parasitologia: Rio de Janeiro, Brazil, 2001.
4. Symmers W. Note on a new form of liver cirrhosis due to the presence of the ova of Bilharzia hamatobia. J Pathol 1904; 9: 237-239.
5. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003; 86: 125-139.
6. Dessein AJ, Couissinier P, Demeure C, Rihet P, Kohlstaedt S, Cameiro-Carvalho D et al. Environmental, genetic ana immunological factors in human resistance to Schistosoma mansoni. Immunol Invest 1992; 21: 423-453.
7. Butterworth AE, Capron M, Cordingley JS, Dalton PR, Dunne DW, Kariuki HC et al. Immunity after treatment of human Schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg 1985; 79: 393-408.
8. Abel L, Demenais F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991; 48: 959-970.
9. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J et al Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996; 14: 181-184.
10. Marquet S, Abel L, Hillaire D, Dessein A. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur J Hum Genet 1999; 7: 88-97.
11. Sutherland GR, Baker E, Callen DF, Hyland VJ, Wong G, Clark S et al Interleukin 4 is at 5q31 and interleukin 6 is at 7p15. Hum Genet 1988; 79: 335-337.
12. Takahashi M, Yoshida MC, Satoh H, Hilgers; J, Yaoita Y, Honjo T. Chromosomal mapping of the mouse IL-4 and human IL-5 genes. Genomics 1989; 4: 47-52.
13. Morgan JG, Dolganov GM, Robbins SE, Hinton LM, Lovett M. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res 1992; 20: 5173-5179.
14. Muller-Myhsok B, Stelma FF, Guisse-Sow F, Muntau B, Thye T, Burchard GD et al. Further evidence suggesting the presence of a locus, on human chromosome 5q3l-q33, influencing the intensity of infection with Schistosoma mansoni. Am J Hum Genet 1997; 61: 452-454.
15. Dessein AJ, Begley M, Demeure C, Caillol D, Fueri J, dos Reis MG et al. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface a tigen. J Immunol 1988; 140: 2727-2736.
16. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991; 21: 2679-2686.
17. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ. Resistance to Schistosoma mansoni in humans: Influence of the IgE/ IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993; 168: 1000-1008.
18. Couissinier-Paris P, Dessein AJ. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur J Immunol 1995; 25: 2295-2302.
19. Rodrigues Jr V, Piper K, Couissinier-Paris P, Bacelar O, Dessein H, Dessein AJ. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes. Infect Immun 1999; 67: 4689-4692.
20. Kouriba B, Chevillard C, Bream JH, Argiro L, Dessein H, Arnaud V et al. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol 2005; 174: 6274-6281.
21. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991; 349: 243-245.
22. Peisong G, Yamasaki A, Mao XQ, Enomoto T, Feng Z, Gloria-Bottini F et al. An asthma-associated genetic variant of STAT6 predicts low burden of Ascaris worm infestation. Genes Immun 2004; 5: 58-62.
23. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
24. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG et al. The sequence of the human genome. Science 2001; 291: 1304-1351.
25. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-933.
26. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362-367.
27. Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H et al. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol 2006; 177: 8633-8642.
28. Georas SN, Cumberland JE, Burke TF, Chen R, Schindler U, Casolaro V Stat6 inhibits human interleukin-4 promoter activity in T cells. Blood 1998; 92: 4529-4538.
29. Dorado B, Jerez MJ, Flores N, Martin-Saavedra FM, Duran C, Ballester S. Autocrine IL-4 gene regulation at late phases of TCR activation in differentiated Th2 cells. J Immunol 2002; 169: 3030-3037.
30. Schroder AJ, Pavlidis P, Arimura A, Capece D, Rothman PB. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J Immunol 2002; 168: 996-1000.
31. Vafa M, Maiga B, Berzins K, Hayano M, Bereczky S, Dolo A et al. Associations between the IL-4 -590T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali. Microbes Infect 2007; 9: 1043-1048.
32. Graves PE, Kabesch M, Halonen M, Holberg CJ, Baldini M, Fritzsch C et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000; 105: 506-513.
33. Liu X, Nickel R, Beyer K, Wahn U, Ehrlich E, Freidhoff LR et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multi-center atopy study (MAS-90). J Allergy Clin Immunol 2000; 106 (1 Part 1): 167-170.
34. Leung TF, Tang NL, Chan IH, Li AM, Ha G, Lam CW. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy 2001; 31: 1515-1521.
35. Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Kakinuma T et al Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci 2002; 30: 100-107.
36. van der Pouw Kraan TC, Kucukaycan M, Bakker AM, Baggen JM, van der Zee JS, Dentener MA et al. Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 2002; 3: 436-439.
37. He JQ, Chan-Yeung M, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun 2003; 4: 385-389.
38. Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen LK et al. Association between an interleukin-13 promoter polymorphism and atopy. Eur J Immunogenet 2003; 30: 355-359.
39. Wang M, Xing ZM, Lu C, Ma YX, Yu DL, Yan Z et al. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet 2003; 113: 387-390.
40. Chen W, Ericksen MB, Levin LS, Khurana Hershey GK. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants. J Allergy Clin Immunol 2004; 114: 553-560.
41. Brown RH, Hamilton RG, Mintz M, Jedlicka AE, Scott AL, Kleeberger SR. Genetic predisposition to latex allergy: Role of interleukin 13 and interleukin 18. Anesthesiology 2005; 102: 496-502.
42. Moissidis I, Chinoy B, Yanamandra K, Napper D, Thurmon T, Bocchini Jr J et al. Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans. Genet Med 2005; 7: 406-410.
43. Syed F, Panettieri Jr RA, Tliba O, Huang C, Li K, Bracht M et al. The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir Res 2005; 6: 9.
44. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005; 115: 747-754.
45. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK et al IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006; 117: 269-274.
46. van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER, Stapel SO et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999; 1: 61-65.
47. Howard TD, Whittaker PA, Zaiman AL, Koppelman GH, Xu J, Hanley MT et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001; 25: 377-384.
48. Zhu S, Chan-Yeung M, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J et al. Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med 2000; 161: 1655-1659.
49. Sandford AJ, Chagani T, Zhu S, Weir TD, Bai TR, Spinelli JJ et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 2000; 106 (1 Part 1): 135-140.
50. Noguchi E, Nukaga-Nishio Y, Jian Z, Yokouchi Y, Kamioka M, Yamakawa-Kobayashi K et al. Haplotypes of the 5′ region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol 2001; 62 1251-1257.
51. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997; 337 1720-1725.
52. Wang HY, Shelburne CP, Zamorano J, Kelly AE, Ryan JJ, Keegan AD. Cutting edge: Effects of an allergy-associated mutation in the human IL-AR alpha (Q576R) on human IL-4-induced signal transduction. J Immunol 1999; 162: 4385-4389.
53. Rosa-Rosa L, Zimmermann N, Bernstein JA, Rothenberg ME, Khurana Hershey GK. The R576 IL-4 receptor alpha allele correlates with asthma severity. J Allergy Clin Immunol 1999; 104: 1008-1014.
54. Izuhara K, Shirakawa T. Signal transduction via the interleukin-4 receptor and its correlation with atopy. Int J Mol Med 1999; 3 3-10.
55. Kruse S, Japha T, Tedner M, Sparholt SH, Forster J, Kuehr J et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999; 96: 365-371.
56. Ober C, Leavitt SA, Tsalenko A, Howard TD, Hoki DM, Daniel R et al Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000; 66: 517-526.
57. Oiso N, Fukai K, Ishii M. Interleukin 4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan. Br J Dermatol 2000; 142: 1003-1006.
58. Takabayashi A, Ihara K, Sasaki Y, Suzuki Y, Nishima S, Izuhara K et al. Childhood atopic asthma: Positive association with a polymorphism of IL-4 receptor alpha gene but not with that of IL-4 promoter or Fc epsilon receptor I beta gene. Exp Clin Immunogenet 2000; 17: 63-70.
59. Andrews RP, Burrell L, Rosa-Rosa L, Cunningham CM, Brzezinski JL, Bernstein JA et al. Analysis of the Ser786Pro interleukin-4 receptor alpha allelic variant in allergic and nonallergic asthma and its functional consequences. Clin Immunol 2001; 100: 298-304.
60. Tanaka K, Roberts MH, Yamamoto N, Sugiura H, Uehara M, Mao XQ et al Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. Biochem Biophys Res Commun 2002; 292: 776-780.
61. Risma KA, Wang N, Andrews RP, Cunningham CM, Ericksen MB, Bernstein JA et al. V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function. J Immunol 2002; 169 1604-1610.
62. Webb DC, Matthaei KI, Cai Y, McKenzie AN, Foster PS. Polymorphisms in IL-4R alpha correlate with airways hyper-reactivity, eosinophilia, and Ym protein expression in allergic IL-13-/- mice. J Immunol 2004; 172: 1092-1098.
63. Adjers K, Pessi T, Karjalainen J, Huhtala H, Hurme M. Epistatic effect of IL1A and IL4RA genes on the risk of atopy. J Allergy Clin Immunol 2004; 113: 445-447.
64. Hytonen AM, Lowhagen O, Arvidsson M, Balder B, Bjork AL, Lindgren S et al. Haplotypes of the interleukin-4 receptor alpha chain gene associate with susceptibility to and severity of atopic asthma. Clin Exp Allergy 2004; 34: 1570-1575.
65. Daniel C, Salvekar A, Schindler U. A gain-of-function mutation in STAT6. J Biol Chem 2000; 275: 14255-14259.
66. Tamura K, Arakawa H, Suzuki M, Kobayashi Y, Mochizuki H, Kato M et al Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases. Clin Exp Allergy 2001; 31: 1509-1514.
67. Nagarkatti R, B-Rao C, Vijayan V, Sharma SK, Ghosh B. Signal transducer and activator of transcription 6 haplotypes and asthma in the Indian population. Am J Respir Cell Mol Biol 2004; 31: 317-321.
68. Gao PS, Heller NM, Walker W, Chen CH, Moller M, Plunkett B et al. Variation in dinucleotide (GT) repeat sequence in the first exon of the STAT6 gene is associated with atopic asthma and differentially regulates the promoter activity in vitro. J Med Genet 2004; 41: 535-539.
69. Schedel M, Carr D, Klopp N, Woitsch B, Illig T, Stachel D et al. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J Allergy Clin Immunol 2004; 114: 1100-1105.
70. Pykalainen M, Kinos R, Valkonen S, Rydman P, Kilpelainen M, Laitinen LA et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol 2005; 115: 80-87.
71. Gao PS, Mao XQ, Roberts MH, Arinobu Y, Akaiwa M, Enomoto T et al. Variants of STAT6 (signal transducer and activator of transcription 6) in atopic asthma. J Med Genet 2000; 37: 380-382.
72. Weidinger S, Klopp N, Wagenpfeil S, Rummler L, Schedel M, Kabesch M et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 2004; 41: 658-663.
73. Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 1993; 92: 404-411.
74. Araujo MI, Lopes AA, Medeiros M, Cruz AA, Sousa-Atta L, Sole D et al Inverse association between skin response to aeroallergens and Schistosoma, mansoni infection. Int Arch Allergy Immunol 2000; 123: 145-148.
75. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG et al. Decreased atopy in children infected with Schistosoma haematobium: A role for parasite-induced interleukin-10. Lancet 2000; 356: 1723-1727.
76. Cookson WO, Moffatt MF. Asthma: An epidemic in the absence of infection? Science 1997; 275: 41-42.
77. Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000; 30: 187-193.
78. Kouriba B, Traore HA, Dabo A, Sangare L, Guindo H, Keita AS et al. Urinary disease in 2 Dogon populations with different exposure to Schistosoma haematobium infection: Progression of bladder and kidney diseases in children and adults. J Infect Dis 2005; 192: 2152-2159.
79. Brinkmann UK, Powollik W, Werler C, Traore M. An evaluation of sampling methods within communities and the validity of parasitological examination techniques in the field. Trop Med Parasitol 1988; 39: 162-166.
80. Sambrook JE, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual 1989, 2nd edn. Cold Spring Harbor Laboratory Press: New York, pp 1.3-1.105.
81. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.